Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
carbapenemase detection | test identifies a carbapenem-hydrolyzing enzyme or its genetic determinant | Carbapenemase detection was reported with the method and organism. | Objective | Molecular testing, serology and culture findings |
extended-spectrum beta-lactamase | enzyme capable of hydrolyzing a range of extended-spectrum beta-lactams | Extended-spectrum beta-lactamase was identified in the microbiology comment on the isolate. | Objective | Molecular testing, serology and culture findings |
susceptibility pending | organism identified but antimicrobial susceptibility results are not final | The culture report states "susceptibility pending" for the blood isolate. | Objective | Molecular testing, serology and culture findings |
revised susceptibility report | laboratory amended an earlier antimicrobial susceptibility interpretation | The revised susceptibility report was reviewed with the amendment time and ordering clinician. | Objective | Molecular testing, serology and culture findings |
persistent bacteremia | blood cultures remain positive on serial sampling | Persistent bacteremia was assessed using the organism and collection time for each set. | Assessment | Infection course, epidemiology and source attribution |
recurrent bacteremia | bacteremia appears again after an interval of apparent clearance | Recurrent bacteremia was reviewed against the prior isolate and interval cultures. | Assessment | Infection course, epidemiology and source attribution |
polymicrobial bacteremia | more than one organism recovered from blood in the clinical episode | Polymicrobial bacteremia was documented with separate identification for each isolate. | Assessment | Infection course, epidemiology and source attribution |
bloodstream source attribution | assessment of the most likely origin of a bloodstream infection | Bloodstream source attribution remains uncertain while line and peripheral cultures are compared. | Assessment | Infection course, epidemiology and source attribution |
endovascular focus | suspected infection within the heart or vascular system | The endovascular focus was considered after repeat cultures remained positive. | Assessment | Infection course, epidemiology and source attribution |
metastatic infection | infection seeded at a distant site from another focus | Metastatic infection was considered in light of the new focal spinal pain. | Assessment | Infection course, epidemiology and source attribution |
contiguous spread | infection extends directly from an adjacent infected structure | Contiguous spread was considered where the ulcer overlies the abnormal bone. | Assessment | Infection course, epidemiology and source attribution |
hematogenous spread | dissemination through the bloodstream | Hematogenous spread was considered when a separate deep focus was identified. | Assessment | Infection course, epidemiology and source attribution |
ascending infection | infection progresses upward along a tract | Ascending infection was considered after urinary symptoms preceded flank pain. | Assessment | Infection course, epidemiology and source attribution |
microbiologic relapse | return of infection thought to represent persistence of the original organism | Microbiologic relapse was considered when the same organism recurred soon after therapy. | Assessment | Infection course, epidemiology and source attribution |
colonization pressure | extent of exposure to people or environments carrying a given organism | Colonization pressure was discussed in the unit's epidemiologic review. | Assessment | Infection course, epidemiology and source attribution |
carrier state | organism is present in a person who may have no attributable symptoms | Carrier state was considered when the screening result was reviewed. | Assessment | Infection course, epidemiology and source attribution |
latent infection | infection persists without the clinical features of active disease | Latent infection was documented using the organism-specific evaluation. | Assessment | Infection course, epidemiology and source attribution |
opportunistic infection | infection favored by impaired host defenses | Opportunistic infection was considered given the nature and timing of immunosuppression. | Assessment | Infection course, epidemiology and source attribution |
breakthrough infection | infection develops despite an intervention intended to prevent it | Breakthrough infection was reviewed with prophylaxis exposure and adherence. | Assessment | Infection course, epidemiology and source attribution |
community-onset infection | infection first apparent outside the hospital or near admission under the stated definition | Community-onset infection was classified using the symptom and admission timeline. | Assessment | Infection course, epidemiology and source attribution |
healthcare-associated exposure | potential exposure during a healthcare encounter | Healthcare-associated exposure was identified in the interval before the symptoms began. | Assessment | Infection course, epidemiology and source attribution |
infectious incubation period | time between acquisition of an infection and symptom onset | Infectious incubation period was compared with the dates of the suspected exposure. | Assessment | Infection course, epidemiology and source attribution |
infectious period | interval during which transmission may occur | Infectious period was assessed using the organism-specific public health guidance. | Assessment | Infection course, epidemiology and source attribution |
suspected common source | one exposure may account for multiple cases | The suspected common source was considered because attendees reported illness after the same meal. | Assessment | Infection course, epidemiology and source attribution |
secondary household case | illness in a household contact after an earlier case | Secondary household case was assessed with the sequence of symptom onset recorded. | Assessment | Infection course, epidemiology and source attribution |